Product Program year 2025 Source: CMS Open Payments

Xiaflex

Biological Urology

NDC 66887-003-01

Open in the dashboard

General payments

$5,864,001

71,477 payments

Research payments

$6,328,695

117 payments

Through program year 2025, $5,864,001 in general payments and $6,328,695 in research payments were reported against Xiaflex (Urology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $805,367 12,684
2025 Research $960,214 46
2024 General $986,256 11,229
2024 Research $1,561,246 29
2023 General $874,298 11,241
2023 Research $192,546 9
2022 General $1,062,218 10,729
2022 Research $2,098,289 11
2021 General $708,671 10,007
2021 Research $1,117,074 6
2020 General $584,795 6,679
2020 Research $97,062 5
2019 General $842,395 8,908
2019 Research $302,264 11

Breakdown

Who paid General payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $4,324,734 51,056 payments
  2. Endo USA, Inc. $1,539,266 20,421 payments
Top recipients General payments · program year 2025
  1. Resnick Neuropsychiatric Hospital At Teaching hospital · CA $40,000 5% · 1 payment
  2. Majdee Islam Urology · Saint Peters, MO $37,472 5% · 71 payments
  3. Kristen Gumpf Physician Assistant · Carmel, IN $33,543 4% · 139 payments
  4. Richard Bennett Urology · Royal Oak, MI $17,453 2% · 17 payments
  5. Billy Cordon Urology · New York, NY $16,040 2% · 30 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $522,283 72% · 2,382 practitioners
  2. Physician Assistant $104,675 14% · 579 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $41,797 6% · 527 practitioners
  4. Nurse Practitioner $16,426 2% · 235 practitioners
  5. Nurse Practitioner, Adult Health Nurse Practitioner $11,013 2% · 61 practitioners

The top 5 of 60 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $115,041 14% · 226 recipients
  2. Florida $108,164 13% · 498 recipients
  3. New York $59,043 7% · 314 recipients
  4. Indiana $57,114 7% · 122 recipients
  5. Texas $56,709 7% · 314 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

1,570

Prescriptions dispensed, refills included

Drug cost

$17,778,364

Paid at the pharmacy, in all

Prescribers

96

With 11 or more claims of it

Medicare Part D drugs matched to XIAFLEX, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Xiaflex Collagenase Clostridium Hist. Same name 96 1,570 $17,778,364

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 96 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Igor Ryndin Urology NY 38 $487,010 None on record
Kevin Campbell Urology FL 36 $465,276 $111
Kyle Moyles Hand Surgery FL 35 $277,332 $38
Paul Rusilko Urology PA 34 $409,782 None on record
Walter Wray Hand Surgery NC 30 $298,637 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 96 with Patron

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to XIAFLEX
Billing code Providers Services Paid by Medicare
Injection, collagenase, clostridium histolyticum, 0.01 mg J0775 87 256,513 $13,936,725

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

71,477 general · 117 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record